Matthew Calistri | executive |
Ronald Renaud | executive |
Ramiro Sanchez | executive |
John Renger | executive |
Susan Altschuller | executive |
Michael Yee | analyst |
Paul Matteis | analyst |
Mohit Bansal | analyst |
Lee Hung | analyst |
Graig Suvannavejh | analyst |
Charles Duncan | analyst |
David Amsellem | analyst |
Joseph Thome | analyst |
Good morning, and welcome to the Cerevel Therapeutics Third Quarter Financial Results Conference Call. At this time, all participants are in listen-only mode... Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this call may be recorded. I will now hand the call over to Matt Calistri, Vice President of Investor Relations.